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Mechanism-based Toxicology
Researchers, regulators, and legislators will
come together to look at issues and impli-
cations of using mechanism-based toxicol-
ogy in cancer risk assessment at a work-
shop sponsored by the National Toxi-
cology Program. The workshop, titled
"Mechanism-based Toxicology in Cancer
Risk Assessment: Implications for Re-
search, Regulation, and Legislation" will be
held January 11-13 in Chapel Hill, North
Carolina.
Emerging tools and insights into the
carcinogenic process provided by molecu-
lar biology offer great promise in comple-
menting and improving traditional
approaches in toxicity testing and in
strengthening the scientific foundation on
which risk assessments are based. The
workshop goals are to assess the scientific
foundation for using mechanism-based risk
toxicology to address critical issues in risk
assessment, to identify and propose solu-
tions to the regulatory problems which
may emerge from the use of mechanistic
toxicology, and to determine the applica-
bility of mechanism-based toxicology and
risk assessment to current legislative
issues.The members ofthe plenary session,
"Defining Scientific, Regulatory, and
Legislative Issues," will be: Kenneth
Olden, director,NTP and NIEHS; Lynn
Goldman, assistant director, EPA; Bernard
Schwetz, director, NCTR,FDA; Mark
Schaefer, assistant director for environ-
ment, OSTP; Richard Jackson, director,
NCEH, CDC; Linda Rosenstock, director,
NIOSH; George Lucier, director, ETP,
NIEHS; Carl Barrett, director, ECP,
NIEHS; and Ray Tennant, ECP, NIEHS.
The following five discussion groups will
be presented:
* Mechanism-based toxicology for screen-
ing chemicals and for setting priorities
for carcinogen testing: Linda Birnbaum,
U.S. EPA, Marilyn Wind, U.S. Con-
sumer Product Safety Commission, co-
chairs. The focus of this discussion
group will be on strategies developing
rational approaches for identifying
agents that should be further evaluated
and testing classes of chemicals that
share common structural or biological
properties. Alternative or flexible designs
of bioassays to test hypothesis that will
impact on our understanding ofthe haz-
ards of a series of chemicals/compounds
are an important aspect of this discus-
sion group. Included are alternative test
systems, human epidemiological studies,
and ecotoxicological studies. Short-term,
mechanistic-based approaches to testing
mixtures ofchemicals are also relevant.
* Mechanism-based toxicology in carcino-
gen hazard identification: Hiroshi
Yamasaki, International Agency for
Research on Cancer, William Farland
U.S. EPA, co-chairs. Strategies for iden-
tifying or predicting chemicals reason-
ably anticipated to be carcinogenic to
humans in the absence of two-year
rodent bioassay results will be addressed.
The type and extent of data necessary
(for example, structure activity, genotox-
icity, receptor-mediated effects, and
other biological activities) to predict and
classify a chemical as potentially haz-
ardous will be discussed. The intent is to
identify potential carcinogens on the
basis of mechanisms to provide strong
evidence predicting a negative response.
The extent to which this information
can be used for setting priorities for fur-
ther studies and for regulatory actions is
a key point for discussion.
Mechanism-based toxicology for deter-
mining dose-response relationships for
chemical effects and low-dose extrapola-
tion: Michael Gallo, Robert Wood
Johnson Medical School and Rutgers
University, James W. Stratton, Cali-
fornia Environmental Protection
Agency, co-chairs. This group will dis-
cuss the use ofmechanistically important
endpoints other than tumor formation
for determining dose-response relation-
ships and low-dose extrapolation and the
impact of this approach to risk assess-
ment. Experimental and mathematical
approaches to dose-effect relationships
and the data necessary to predict tumor
responses from mechanistic-based end-
points within the framework of multi-
stage models need to be addressed. Of
particular interest is the development of
credible strategies for low-dose risk esti-
mates.
* Mechanism-based toxicology for species
extrapolation: Joseph Contrera, U.S.
Food and Drug Administration, James
Swenberg, Department of Environ-
mental Sciences and Engineering,
University of North Carolina at Chapel
Hill, co-chairs. This group will discuss
how to use mechanistic information for
species extrapolation.
Given that mechanisms
ofaction are never com-
pletely understood, how
can current advances in
mechanisms ofaction of
chemicals be used to
predict responses in dif-
ferent species for differ-
ent classes of chemicals?
What chemical classes
are currently understood
sufficiently to allow this
analysis? Additional
classes that need to be
studied, multiple mech-
anisms, and general strategies to direct
necessary research to support mechanis-
tic arguments will be discussed.
Mechanism-based toxicology to deter-
mine distributions of risk: Carol Henry,
U.S. Department of Energy, John Davis
Groopman, Johns Hopkins University,
co-chairs. Individuals vary greatly in their
responses to chemically induced toxicity.
Given this fact, current risk assessment
methods assume that the most suscepti-
ble rodent represents the most susceptible
human. This public health-based
assumption can overestimate or underes-
timate risks to humans. Given the recent
advances in identifying the basis ofgenet-
ic susceptibilities for chemicals in
humans and rodents as well as age and
gender-dependent differences, how can
we design experiments to determine the
distribution ofrisks among different pop-
ulations? Another topic for the group will
be the use of mechanistic approaches to
more accurately determine exposure so
that genetic/environment interactions
can be assessed more accurately.
Kenneth Olden, director of the NTP
and the NIEHS, said, "Key to the success
of the workshop will be the inclusion of
the needs, views and issues of federal and
state regulatory agencies, industry, labor,
environmental organizations, legislators,
the broader scientific community, and the
public." He noted that discussion groups
will be asked to develop recommendations
and to identify areas of concensus, dis-
agreement, knowledge gaps, and how to
most efficiently address those gaps.
The workshop will be open to the pub-
lic on a space-available basis, and a public
comment session will provide the opportu-
nity for additional views and comments.
For registration and additional informa-
tion, contact Sandy Lange, NTP Liaison
Office, NIEHS, PO Box 12233, Research
Triangle Park, NC 27709; (919) 541-
0530, FAX (919) 541-0295.
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David P. Rail
Rail Returns to
NIEHS
"Prevention is not very
exciting," said David P. Rall
at the beginning of a pre-
sentation on his first return
to the NIEHS since retiring
in 1990 after 19 years as
director. "You don't get any
kudos from your patients
whom you've protected
from sure death. You don't
even know whom you've
helped. But prevention of
disease is a task that ulti-
mately must be done."
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